|
Marshfield implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Marshfield Clinic Research Foundation |
Case, Control |
71 |
435 |
100%, 100% |
100% |
|
Group Health/University of Washington CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Group Health/University of Washington |
Case, Control |
300 |
4,475 |
96%, 100% |
|
|
Marshfield Implementation 2 |
CAAD (Carotid Artery Atherosclerosis Disease) |
Marshfield Clinic Research Foundation |
Case, Control |
193 |
4,170 |
100%, 100% |
|
|
Mayo Clinic CAAD Evaluation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mayo Clinic |
Case, Control |
|
|
100% |
72% |
|
Mayo CAAD cases and controls |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mayo |
Case, Control |
13 |
|
100% |
71% |
|
Mount Sinai Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mount Sinai School of Medicine |
Case, Control |
105 |
5,180 |
|
|
|
Geisinger CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Geisinger |
Case, Control |
|
|
|
|
|
Vanderbilt CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Vanderbilt University |
Case, Control |
128 |
4,571 |
|
|
|
Northwestern Univ. CAAD |
CAAD (Carotid Artery Atherosclerosis Disease) |
Northwestern University |
Case, Control |
44 |
461 |
|
|
|
CAAD Implementation - Columbia |
CAAD (Carotid Artery Atherosclerosis Disease) |
Columbia University |
Case, Control |
9 |
1,530 |
|
|
|
Geisinger eMERGE III Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Geisinger |
Case, Control |
1,795 |
8,838 |
|
|
|
Harvard CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
|
Case, Control |
140 |
3,961 |
|
|
|
Mayo Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
|
Case, Control |
416 |
278 |
|
|
|
Nortwestern University e3 Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Northwestern University |
Case, Control |
48 |
133 |
|
|
|
NU Validation and Results |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Northwestern University Feinberg School of Medicine |
Case, Control |
334 |
720 |
98%, 92% |
92%, 98% |
|
VU Implementation |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Vanderbilt University |
Case, Control |
1,642 |
2,862 |
|
|
|
GH/UW Verification |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Group Health and University of Washington |
Case, Control |
479 |
319 |
100%, 100% |
100%, 100% |
|
CHOP implementation |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
CHOP |
Case, Control |
|
|
92%, 100% |
|
|
Harvard Implementation |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Harvard Medical School |
Case, Control |
573 |
1,446 |
|
|
|
GERD Implementation - Columbia |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Columbia University |
Case, Control |
76 |
259 |
|
|
|
Vanderbilt Implementation of CHD |
MidSouth CDRN - Coronary Heart Disease Algorithm |
Vanderbilt University |
Case Only |
|
|
98% |
95% |
|
Coronary Heart Disease-Columbia |
MidSouth CDRN - Coronary Heart Disease Algorithm |
Columbia University |
Case Only |
|
|
|
|
|
Appendicitis Implementation - Columbia |
Appendicitis |
Columbia University |
Case, Control |
21 |
3,038 |
|
|
|
Vanderbilt March 2016 |
Appendicitis |
Vanderbilt University Medical Center |
Case, Control |
|
|
|
|
|
appendicitis CHOP eMERGE III |
Appendicitis |
CHOP |
Case, Control |
|
|
|
|
